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ABSTRACT OF THE THESIS
Dynamic Genetic Control:
Manipulating Cell Behaviors Using Heat
by
Yanmin Ji
Master of Science in Bioegnineering
University of California, San Diego, 2017
Professor Peter Yingxiao Wang, Chair
Although Chimeric Antigen Receptor (CAR) T cells have been proven to be
powerful in eradicating tumors. However, its non-specific activity against normal tissues
and cells has been a major problem. Here, utilizing the activation of transient receptor
potential cation channel subfamily V member 1 (TRPV1) under heat, the translocation
of nuclear factor of activated T-cells (NFAT) triggered by Calcium influx, and the
recombination effects of Cre-lox system, we have developed a system to remotely
manipulate the expression of proteins in cells under the control of both heat and drugs.
The significance of this project is to provide a method to precisely control the activities
ix
of CAR T cells within targeted local tissues.
x
Chapter 1
Background
Chimeric antigen receptor (CAR) T cell therapy is a potential method to treat
cancer, paticularly with the benefit of having the resultant central memory T cells that
can last for years in suppressing the cancer relapse suppression [1]. This treatment
engineers T cells with a synthetic CAR that control them to kill malignant cells. CAR-
expressing T cells have been proved to have the potential to cure leukemia and other
cancers [1]. However, one major problem raised from clinical trials is that the non-
specific activity against normal, non-malignant cells can be life-threatening [2]. In fact,
off-tumor toxicities against the lung, gray matter in the brain, and cardiac muscles, have
been caused multiple cases of deaths [3, 4]. Therefore, there is an urgent need of a precise
control system to control the effects of CAR T cell therapy within local tissues. Although
cells can be remotely manipulated by multiple different stimulations, one key factor of
the viability of cells is the length of exposure. Thus, the first step towards finding a
precise way to control cells is to design an efficient control system that can deliver the
external signal in a relatively short time. Aiming to shorten the time of stimulation, this
project utilized several control components that have been demonstrated in mammalian
cells, and combined them to dynamically control cells’ response.
1
2This section provides the essential background for all components of the control
system used in this project: transient receptor potential cation channel subfamily V mem-
ber 1 (TRPV1), nuclear factor of activated T-cells (NFAT), and Cre-Lox recombination
system.
1.1 Heat-activatable channel TRPV1
In 1997, TRPV1 was discovered as an sensitive receptor for Capsaicin, the
essential ingredient in ‘hot’ peppers. [5]. Sensory neurons expressing TRPV1 channels
were observed to have significant calcium influx with the presence of Capsaicin. After
transfecting human embryonic kidney 293 (HEK 293) cells with cloned TRPV1 channels,
these cells were observed to be activated by sudden changes in temperature with an in
vitro threshold of 43 °C. These suggests that TRPV1 channels might stay inactivated
at normal temperature of human body (37 °C). However, further investigations need to
be done to confirm the leakage at lower temperature. Besides noxious temperature and
capsaicin, the signals/drugs that can activate/deactivate TRPV1 channels are still being
discovered [6]: mild acidification [7]; bradykinin [8]; nerve growth factor [9]; anadamide
[10]; arachidonic acid metabolites [11]; lipoxygenase products [12]; leukotriene B4 [13];
prokineticins. [14].
Furthermore, molecular biology researches proved that TRPV1 is a putative six-
transmembrane-spanning protein with a pore region between transmembrane segments 5
and 6 [6]. According to cation current across the membrane, TRPV1 is determined to
be an non-selective cation channel but with a high calcium ion permeability [5]. The
response of TRPV1 channel to stimulations has been shown to be dynamically complex
and have the tendency of adapting or desensitizing with continuous stimulations, such as
heat and capsaicin, in sensory neurons [15, 16]. This phenomenon of desensitizing, at
3least partially, depends on the extracellular calcium ions [16, 17].
Besides TRPV1, some other members in transient receptor potential (TRP) family
can also be activated by heat at different levels. For example, TRP subfamily ankyrin,
member 1 (TRPA1) can be activated at temperature lower than 17 °C [18]; TRP subfamily
melastatin, member 8 (TRPM8) can be activated at temperature lower than 23 °C [19];
TRP subfamily vanilloid, member 2 (TRPV2) can be activated at temperature above 53
°C [20]; and TRP subfamily vanilloid, member 3 (TRPV3) can be activated at temperature
above 33 °C [21]. Considering the ultimate goal of this project is to manipulate cells’ in
vivo behavior, the threshold of the chosen channel should be slightly above the routine
temperature, but absolutely lower than extremely noxious temperature. Therefore, TRPV1
was considered as the primary choice for the project.
1.2 Nuclear translocation of NFAT
NFAT refers to a group of transcription factors that plays essential roles in immune
system. Although first discovered in activated T cells, different NFAT family members
have been identified in all cell types that have been investigated. NFAT family current has
five members: NFAT1 (or NFATc2), NFAT2 (or NFATc1), NFAT3 (or NFATc4), NFAT4
(or NFATc3) and NFAT5. While NFAT5 is regulated by osmotic stress [22], all other
four NFAT members are controlled by calcium influx [23]. Also, all NFAT members
except NFAT 3 are discovered in immune system. Researchers have demonstrated that the
calcium flow from intracellular stores is not sufficient to stimulate the function of NFAT
[24], proving that NFAT should be relatively tightly regulated by calcium influx across
the cell membrane. The molecular construct of NFAT suggests that NFAT can shuttle
between the inside and the outside of the nucleus because of its nuclear localization
signal (NLS) and nuclear exportation signal (NES). It is the balance of these two signals
4that induces the shuttling of NFAT across the nuclear envelope.
Figure 1.1: Calcium ions trigger the nuclear translocation of NFATc1: when NES is
exposed, NFATc1 is kept out of the nucleus. With the presence of Calcium influx,
calcineurin (CaN) will be activated and dephosphorylate NFATc1 to induce the confor-
mational change, which can expose NLS of NFATc1. After NLS is exposed, NFATc1
will translocate into the nucleus. Then, with the help of maintenance kinase, NES will
be exposed again, leading NFATc1 to shuttle back to the cytoplasm.
Calcium influx is essential to the translocation of NFAT because of calcineurin
(CaN), a calcium-dependent serine-threonine phosphatase. The influx of calcium ions
can activate calmodulin (CaM) by having calcium ions binding to the four calcium
binding sites of CaM. Then, CaM can bind to the regulatory domain (RD) of CaN, and
introduce a change in conformation, which pushs an autoinhibitory domain (AID) out
of the active site, and activates the function of CaN [25]. The activated CaN, in turn,
rapidly dephosphorylates the SP-repeats and the serine-rich region within the N terminus
of the cytoplasmic components (NFATc proteins) [26]. The dephosphorylation of NFATc
proteins leads to some conformational changes, and exposes its NLS for recognition,
which induce the nuclear translocation of the NFATc protein, as shown in Figure 1.1.
After translocating into the nucleus, if the NFATc protein is phosphorylated again, another
conformational change will happen to expose its NES, and translocate the protein back
into the cytoplasm, stopping any NFAT-mediated transcription. It needs to be mentioned
that maintenance kinases and export kinases also help in regulating the activities of NFAT.
5Maintenance kinases help to keep NFATc proteins out of the nucleus prior to calcium
influxes, while export kinases help to export NFATc proteins after their phosphorylation
[27].
1.3 Cre-lox recombination system
Cre-lox recombination system is a site-specific gene editing system that utilizes
Cre recombinase, and can be used for inversions, deletions and translocations. Cre-lox
recombination system have been applied in various different fields after its discovery:
from inducing gene expression in mammalian cells [28], editing DNA sequence in
developing T cells [29], to generating site- and organ-specific mouse lines [30].
Cre recombinase is a 38-kDa tyrosine recombinase enzyme first isolated from
P1 Bacteriophage. It is believed to be essential in the process of rearranging genome
after DNA replication in P1 [31]. The enzyme achieves site-specific gene editing using a
mechanism similar to that of type I topoisomerase. As illustrated in three-dimensional
structural data, Cre recombinase has a divergent helical N-terminal, and a more uniform
and relatively helical C-terminal, forming a C-shaped site for the binding of the enzyme
and DNA. When the enzyme recognizes two lox sites on the target sequence, it can
modify the gene based on the relative positions and orientations of these two lox sites.
There are three possible situations when Cre recognizes two lox sites as shown in
the Figure 1.2: first, if two lox sites are on the same DNA sequence, and have the same
orientation, then anything between two lox sites will be deleted as circular DNA. Second,
if two lox sites exist on the same DNA sequence, but have opposite orientations, then the
sequence between two lox sites will be inverted. Lastly, if two lox sites are on different
DNA sequence, but same orientation, then one half of the first sequence will switch with
the same half of another sequence.
6Figure 1.2: Different scenarios of Cre-lox recombination system: (from left to right)
inversion, deletion and translocation. Blue triangles are lox sites with different orienta-
tions
In order to improve the specificity and efficiency of Cre-lox system, researchers
have modified the system in three ways: translocation of Cre, spliting Cre, and com-
bination of different lox sites. A typical application of the translocation of Cre is its
combination with estrogen ligand-binding domain (ERT2) [32]. The fusion protein Cre-
ERT2 stays out of the nucleus without any stimulation. With the presence of Tamoxifen,
Cre-ERT2 will translocate into the nucleus, and have Cre functioning with lox sites.
Another way to improve the performance of Cre is to split intact Cre into two halves.
For example, Kirchhoff et al. constructed Cre 19-59 and Cre 60-343, and fused both
fragments with the constitutively dimerizing coiled-coil leucine zipper domain of GCN4
to facilitate the association of two constructs[33]. Furthermore, different combinations
of various lox sites have been proved to have effects on the function of Cre.
Chapter 2
Results
2.1 Initial Design
TRPV1 channel, as it can be activated at 43 °C, which is significantly higher than
the regular human body temperature, was used as the main control of our system. Since
TRPV1 has higher sensitivity to Calcium than that to any other ions, NFATc1, nuclear
translocation of which depends on Calcium influx, was fused to control the localization
of Cre. Lox-containing reporter loxH-ZsGreen-STOP-loxP-mCherry (Cre Stoplight)
should stay within the nucleus. At basal level, as shown in Figure 2.1, Cre-NFATc1 will
stay out of the nucleus, separating Cre and lox sites and having no recombination. At this
time, Cre Stoplight should constitutively express ZsGreen. After heat is applied, TRPV1
channel will introduce Calcium influxes, activating the nuclear translocation of NFATc1,
which will bring Cre together into the nucleus. Thus, Cre can recognize lox sites on Cre
Stoplight, delete ZsGreen-Stop part, and convert ZsGreen signals to mCherry signals.
7
8Figure 2.1: Schematics of Cre-NFATc1: at basal level, without heat, the construct
Cre-NFATc1 stays out of the nucleus, the reporter stays in the nucleus, and the cells
constitutively express ZsGreen proteins; after heat is applied, Ca2+ influx will be
introduced by TRPV1 channels. Ca2+ ions, in turn, will activate nuclear translocation
of NFATc1, which is fused to Cre. After Cre is pulled into the nucleus by NFATc1, it
should recognize two lox sites on the reporter construct, and cut out the gene in between
two lox sites, leading cells to change color from green to red
2.1.1 Characterizing single elements
Before constructing different constructs, the minimal concentration required for
each single component of the control system was tested. Enhanced Green Fluorescent
Protein (EGFP) was fused to NFATc1 proteins, and expressed in HEK 293T cells to verify
its translocation. By using Ionomycin, an ionophore that is generally used to increase
the intracellular level of Calcium (Ca2+), NFATc1 was observed to start shuttling into
the nucleus right after the addition of 1 µM the drug, and stay inside the nucleus for
at least 20 minutes. The relative nuclear localization increased about twice after the
treatment. Then, the fusion protein between EGFP and NFATc1 was tested coupled with
TRPV1 channel to determine its feasibility of controlling by heat. As shown in Figure
2.2, although the background is relatively high, the increase of nuclear localization was
significant as the heat time increases. Then, the heterodimerization of FKBP/FRB was
tested together with Cre 19-59 (FKBP-CreN) and Cre 60-343 (FRB-CreC) respectively.
9(a) (b)
Figure 2.2: Nuclear translocation of EGFP-NFATc1 under under heat: (a) shows the
typical GFP-channel fluorescence imaging before any heat; (b) shows the change in
relative nuclear localization as exposure time increases.
2.1.2 Engineering intact Cre with NFATc1
To keep the construct similar, we fused Cre and NFATc1 with the same linker
from the fusion protein of EGFP and NFATc1 (SGLRS). After treating cells with heat
for different time lengths, the mCherry signal in cells had no difference from the signal
from the background, as shown in Figure 2.3. Therefore, we suspected: (1) the efficiency
of our Cre-lox system was so low that the signal could not be captured; (2) the linker
was too short that NFATc1 interfered the activity of Cre. Since we have demonstrated
that FKBP-CreN and FRB-CreC can work fine with the presence of AP21967, and the
efficiency of separated Cre is expected to be lower than that of intact Cre, the scenario (1)
should not be the problem. Therefore, we started to optimize the linker between Cre and
NFATc1. Since we have previously demonstrated the function of FKBP/FRB-CreN/CreC
and Cre-ERT2, we then tested whether the linkers from these two constructs could be used
for the fusion of Cre and NFATc1. The linker from FKBP-CreN (ASPSNPGASNGS)
and the linker from Cre-ERT2 (RLLEDGDLEP) were used to construct Cre-L1-NFATc1
and Cre-L2-NFATc1 respectively. The in vitro performance of these two constructs was
10
shown in Figure 2.4 While the recombination signal from Cre-L1-NFATc1 was still
similar to the background, the signal from Cre-L2-NFATc1 was significantly higher than
the background. However, it should be noticed that although the recombination efficiency
of Cre-L2-NFATc1 was guaranteed, the leakage of signal was so high that the difference
between the negative control group (no heat) and the experimental group was hard to
determine. Therefore, we proposed to include FKBP/FRB as another layer of control
into the system.
Figure 2.3: in vitro performance of Cre-NFATc1: the mCherry signal from Cre-NFATc1
after recombination was so weak that it was possible to be auto-florescence.
11
(a) (b)
(c) (d)
Figure 2.4: Comparison between different Cre-NFATc1 constructs: blue line: basal
level, red line: after 10 minutes heat at 43 °C. As shown from (b) and (d), the mCherry
signal was still weak with Cre-L1-NFATc1. For Cre-L2-NFATc1, from (c) and (e),
although the background at the basal level is much higher than other constructs, the
change between basal level and the experimental group is more significant than others.
2.2 Improved Design
Considering the fact that the combination of TRPV1 channel and NFATc1 has
severe leakages even at the basal level, we started thinking to have another layer of
controlling. The heterodimerization of FKBP and FRB, which is a great example of
chemically induced dimerization (CID) system, was adapted into our system to provide a
more precisely controlling. Discovered in 1996, FKBP and FRB can bind to each other
12
only with the presence of Rapamycin, a small molecular drug, or AP21967, a derivative
of Rapamycin[34]. Therefore, ideally, at the basal level, FKBP-CreN-NFATc1 should
stay out of the nucleus, and cells should solely express ZsGreen signal, as shown in
Figure 2.5a. Then, with temperature increases to 43 °C, NFATc1 should be translocated
into the nucleus. With no presence of Rapamycin, FKBP and FRB, as well as CreN and
CreC should be separated, leading cells to express ZsGreen protein only. However, if we
add Rapamycin after the temperature increases, FKBP and FRB will bind to each other,
pulling CreN and CreC to form the intact Cre, in the nucleus. Therefore, we can observe
the change in colors only if we apply both heat and Rapamycin on the cells, as shown in
Figure 2.5b.
(a) (b)
Figure 2.5: Schematics of FKBP-CreN-NFATc1 and NLS-FRB-CreC: at the basal
level, FKBP-CreN-NFATc1 stays out of the nucleus, while the reporter construct and
NLS-FRB-CreC are constrained in the nucleus, and the cell should only have green
signal (ZsGreen), as shown in (a). After heat is applied, FKBP-CreN-NFATc1 will be
translocated into the nucleus. However, because of the absence of Rapamycin, FKBP
and FRB cannot bind to each other, meaning the intact Cre cannot be formed. After
the addition of Rapamycin, FKBP and FRB will bind together, pulling CreC and CreN
to form the intact Cre, and, thus, Cre can function with lox sites to complete deletion,
changing color from green to red (mCherry), as shown in (b)
2.2.1 Utilizing FKBP/FRB with split Cre
As shown in Figure 2.7, comparing with Cre-L2-NFATc1, FKBP-CreN-NFATc1
working together with NLS-FRB-CreC can have significant color change after the treat-
13
(a) (b)
Figure 2.6: Schematics of FKBP-CreN-NFATc1 and NES-FRB-CreC: at the basal
level, FKBP-CreN-NFATc1 and NES-FRB-CreC both stay out of the nucleus, while the
reporter construct is in the nucleus, and the cell should only have green signal (ZsGreen),
as shown in (a). After Rapamycin is added, FKBP and FRB should bind to each other,
pulling CreC and CreN to form the intact Cre. Then, when heat is applied, the whole
construct can be translocated into the nucleus. The intact Cre can now function with lox
sites to complete deletion, changing color from green to red (mCherry), as shown in (b)
ment of heat and drug. However, it was noticed that even with Rapamycin only but no
heat, majority of transfected cells can already express mCherry proteins, as in Figure
2.7c. The possible reason might be: (1) the leakage of TRPV1 allows the shuttling of
NFATc1 at the basal level; (2) nonspecific FKBP/FRB heterodimerization allows the
binding of Cre without Rapamycin; (3) the leakage of NFATc1 leads to uncontrolled
translocation of NFATc1. In scenario (1), it was reported previously that the activation
of TRPV1 channels is not strictly regulated [6]. However, cells transfected with FKBP-
CreN-NFATc1 and NLS-FRB-CreC did not show any difference by culturing them at
33 °C and 37 °C. For scenario (2), previous examination of NLS-FKBP-CreN and NLS-
FRB-CreC also showed minor leakages, but not as severe as the one fused with NFATc1.
Therefore, the main focus was to work on the scenario (3) to keep FKBP-CreN out of
the nucleus before any treatment. To reduce the power of NLS contained in NFATc1,
another NES was inserted at the front of FKBP-CreN-NFATc1 or to replace the NLS in
NLS-FRB-CreC. For groups containing NES-FRB-CreC, the workflow is different from
other constructs: Rapamycin needs to be added first to form the heterodimer between
14
FKBP and FRB, then heat is applied to translocate the two constructs together, as shown
in Figure 2.6. Two NES signals were selected because they were neither too strong to
affect the translocation, nor too weak to have no effect: a relatively strong (nuclear factor
kappa-light-chain-enhancer of activated B cells) NFkB inhibitor alpha (NFkBI) and a
relatively weaker truncated 9cAMP-dependent protein kinase) PKI inhibitor alpha (PKIt)
NES. Besides, different combinations of NESs were tested to find the most optimal
solution.
(a) (b)
(c)
Figure 2.7: Comparisons between Cre-L2-NFATc1 and FKBP-CreN-NFATc1 + NLS-
FRB-CreC: blue line: basal level, red line: after 10 minutes heat at 43 °C. From (a), the
difference between the control group and the experimental group was hard to recognize
for Cre-L2-NFATc1. However, from (b), the experimental and the control group were
separated for FKBP-CreN-NFATc1+NLS-FRB-CreC. (c) shows fluorescence images
for FKBP-CreN-NFATc1 + NLS-FRB-CreC. Left: before any heat or drug; right: after
the addition of AP21967 and 10mins at 43 °C
15
(a)
(b)
(c) (d)
(e) (f)
Figure 2.8: Comparisons between different fusions of NESs and FKBP-CreN-NFATc1
+ FRB-CreC: Fig (a) shows all constructs used for comparison, with each row as a group.
Fig (b) NFkBI NES-FKBP + NLS-FRB; Fig (c) PKIt NES-FKBP + NLS-FRB; Fig (d)
FKBP + PKIt NES-FRB; Fig (e) NFkBI NES-FKBP + PKIt NES-FRB; Fig (f) PKIt
NES-FKBP+PKIt NES-FRB
Chapter 3
Discussion
Leakage is one of the most important concerns of this project, mainly because
Cre-lox recombination is irreversible, meaning that low-level leakage may result in
significant noises over time. In the process of characterizing single elements for the
initial design, it is noticed that although most of cells has dimmer signal from EGFP-
NFATc1 within the nucleus than that from the outside of the nucleus, significant leakages
are still observed before any treatment. The possible reasons are: (1) since Calcium
ions are broadly used for signaling and other activities within cells, it is possible that
the spontaneous Calcium ions influxes within the cells can induce the translocation of
NFATc1; (2) NFATc1 itself is not tightly regulated, which means even there is no Calcium
ion influx, some of NFATc1 proteins will still shuttle across the nuclear membrane. The
scenario (1) is still hard to determine, mainly because detaching or washing cells will
possibly disturbing their balances of Calcium ions. The scenario (2) can be easily solved
by adding additional stronger NES sequence in front of the construct, which has been
done in this project. It is possible that the additional NES is too strong that the NLS
within the NFATc1 protein cannot function normally. However, it can be predicted that
an appropriate NES can keep the balance just fine, so that it can both alleviate the leakage
16
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of NFATc1 and allow some extents of NLS to translocate NFATc1 into the nucleus. Also,
the leakage of TRPV1 is noticed at the temperature below 43 °C. This phenomenon can
be predicted as the threshold of TRPV1 channel, instead of an exact temperature, is a
broad range of temperature. In fact, Davis et al. have reported that TRPV1 channels
can be activated by temperatures from 33 to 54 °C [35]. Therefore, it might be useful to
keep cells at lower temperature prior to any treatment to keep lower background. Also,
considering the leakage at temperatures lower than the threshold, another TRP family
proteins with higher threshold temperature can be used to partially activated at a relatively
high temperature. Additionally, the leakage from the heterodimerization of FKBP/FRB
exists, but the magnitude is so small that it can be neglected for now.
In the combination of FKBP-CreN-NFATc1 and NLS-FRB-CreC, although the
significant background can be observed from no heat with AP21967 group, the increase
from negatively control group to the experimental group is still obvious. Considering
the fact that drug, instead of heat, contributes the most to the control of the system, it is
reasonable to predict that FKBP-CreN-NFATc1 is already translocated into the nucleus
before any heat. This phenomenon echoes with the discussion regarding the leakages of
single elements mentioned above, and proves that the leakage of NFATc1 should be the
most severe factor. Transfected cells have also been cultured at different temperatures
(e.g. 30 °C and 33 °C) to examine if TRPV1 contributes to the leakage of NFATc1, and
the results shows that different culturing temperature does not significantly affect the
translocation of NFAT. Therefore, the main focus should be on keeping NFATc1 out of
the nucleus prior to any treatment.
In the final design, different NESs are examined to find the most optimal combi-
nation. From the result, it should be observed that all of them show different levels of
difference between no heat with Rapamycin (AP21967) groups and experimental groups.
From Figure 2.8, the peak ratio for experimental group s(applied both AP21967 and 43
18
°C temperature) is consistently larger than that for both no treatment group and no heat
with AP21967 group, demonstrating that increases in temperature can be used to switch
the gene expression from ZsGreen to mCherry. To determine which the best combination
is, we mainly focus on the right peak on the plot, if there is any. For the peak on the left,
which has lower average ratio, it is possible to the the mixture of real recombination signal
and nonspecific cell activities (such as cell growth or cell morphology changes with the
drug). However, for the right peak, by closely examining the raw imaging data, majority
of the cells have real and high mCherry/ZsGreen ratio. Out of all these experimental
groups, the combination of PKIt NES-FKBP-CreN-NFATc1 + NLS-FRB-CreC has the
largest increase because it has the largest difference in the right peak between the drug
only group and the heat group. Also, since the x axis is in log scale, it is expected that the
difference between each group will be much more significant. Therefore, we conclude
that we obtained the preliminary sucess on designing a high-precision control system for
CAR-T cell activation.
In the future, much stronger NESs, such as human immunodeficiency virus type
1 Rev Protein (HIV) NES, can be tested to better control the nuclear translocation of
NFATc1 proteins. Also, other TRP subfamily proteins can be tested in order to eliminate
the leakage of TRPV1 channels at lower temperatures. If the leakage can be successfully
limited, since all components of the system have been broadly used in animals by other
researchers, this system can directly be tested on animal models by replacing fluorescence
proteins of the reporter with other components, such as CAR.
In conclusion, based on the heat sensitivity of TRPV1 channels, nuclear translo-
cation of NFAT proteins, heterodimerization between FKBP and FRB and Cre-Lox
recombination system, we successfully build a control system to switch gene expression
under heat simulations. Although leakage is still one of the most important concerns
of the system, we have demonstrated that this issue can be alleviated by the addition of
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NES in the constructs, and possible can be eliminated by stronger NESs. Therefore, the
preliminary success of this control system has been demonstrated.
Chapter 4
Materials & Methods
Plasmids: The initial Cre-NFAT was constructed by replacing EGFP in EGFPC1-
huNFATc1EE-WT. Cre-L1-NFATc1 and Cre-L2-NFATc1 were constructed by cloning
Cre and NFATc1 separately and inserted together into a pcDNA vector. NLS sequence at
the beginning of FKBP-CreN was deleted by primer prior to any design. FKBP-CreN-
NFATc1 was constructed by cloning FKBP-CreN and NFATc1 separately and inserting
both constructs in a pcDNA vector. Additional NESs were cloned in front of FKBP or
FRB by primers. Different versions of the reporter, Cre Stoplight was constructed by
cloning different pieces separately and combining in to a pcDNA vector. Because of
multiple repeated pieces, all constructs were assembled using Gibson Assembly. The
constructs were transformed into DH5a competent E. coli cells for DNA amplification.
DNA was then extracted using Sigma-Aldrich GenEluteTM Plasmid Miniprep kit and
verified by both digestion and sequencing.
EGFPC1-huNFATc1EE-WT was a gift from Jerry Crabtree (Addgene plasmid
# 24219). PcDNA DiCre 59.F2 and pcDNA DiCre 60.F2 were gifts from Jean-Paul
Herman (Addgene plasmid # 60207 and # 60208). PVQ CMV NanoV1-2a-EGFP ferritin
was a gift from Jeffrey Friedman (Addgene plasmid # 79649). Cre Stoplight 2.4 was a
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gift from Thomas Hughes (Addgene plasmid # 37402).
Cell preparation: HEK cells were cultured in Advanced DMEM media (Gibco)
added with 10% FBS, penicillin-streptomycin, and L-glutamine, transfected in transfec-
tion media (no penicillin-streptomycin added). Cells were cultured at 37°C in a 5%-CO2
and 95%-humidified incubator. Transfection was conducted with the Lipofectamine 3000
kit (Sigma-Aldrich) about 48 hours before imaging in transfection media. Experimental
groups were treated about 16-24 hours before imaging. 500nM AP21967 (Clontech), a
derivative of Rapamycin, and 1nM Ionomycin were also added right before the treatment,
depending on the design of the experiment. Heat treatment was done by another 43°C
5%-CO2 and 95%-humidified incubator. For imaging, cells were then plated onto glass-
bottom dishes (Cell E&G) coated overnight with fibronectin at 20 µg/mL concentration
in culturing media 24 hours before imaging. For flow cytometry, cells were washed twice
with PBS, detached with 0.5x trpysin-EDTA, neutralized with double-volume culturing
medium, centrifuged with 1,000 rpm for 3 minutes, and resuspended in PBS right before
the experiment.
Imaging acquisition and analysis: A Nikon Eclipse Ti inverted microscope
installed with a 300 W Xenon lamp (Atlas Speialty Lighting), an electron multiplying
(EM) CCD camera (QuantEM:512SC, Photometrics), and 100x, 40x and 10x DIC Nikon
microscope objectives were used to capture all imaging data with the MetaMorph 7.8.8.0
software (Molecular Devices) or Metafluor 7.8.8.0 software (Molecular Devices). The
microscope is equipped with a EGFP(FITC/Cy2) cube (#49002) and a mCherry/Texas
Red cube (#49008) from Chroma Technology. Image analysis for all the acquired images
was conducted on Fluocell, an image analysis software tool developed in the Wang Lab,
and Quantify, an add-on of Fluocell to automatically analyze multiple cells within the
same figure and calculate the fluorescence ratio, as shown in Figure 4.1.
Flow cytometry data acquisition and analysis: A BD Accuri C6 flow cytome-
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(a) (b)
Figure 4.1: Fluocell can automatically detect and analyze single cells: Fluocell
was used to analyze imaging data. The combination of mCherry channel and Zs-
Green channel were used to detect cells, which were denoted by its white boundaries.
MCherry/ZsGreen ratio was calculated and shown in color for each detected cell. The
ratio from low to high was denoted as blue to red
ter was used to collect flow cytometry data. The flow cytometer has two excitation light:
Blue (488 nm) and Red (640 nm). Two (533/30 nm and 610/20 nm)out of four emission
filters were used for this project. All datas were analyzed using BD Accuri C6 software.
Color compensation was done by adjusting channel intensity based on pure ZsGreen and
mCherry proteins.
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